Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003381 · ClinicalTrials.gov registry record
Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Terminated
- Registry status
- 56
- Enrollment target
NCT00003381 is a clinical trial that was terminated before completion, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 56 participants.
The verdict
NCT00003381 was terminated before completion, sponsored by Alliance for Clinical Trials in Oncology.
- TERMINATED
- Registry status
- 56 participants
- Enrollment target
Study Summary
RATIONALE: Questionnaires that measure quality of life during treatment may improve the ability to plan treatment for patients with esophageal cancer. PURPOSE: This clinical trial is studying the quality of life in patients receiving treatment for esophageal cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 1998-07 |
| Est. Completion | 2005-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003381
The ClinicalTrials.gov registry entry for NCT00003381 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00003381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003381 about?
NCT00003381 is a clinical study titled "Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]". RATIONALE: Questionnaires that measure quality of life during treatment may improve the ability to plan treatment for patients with esophageal cancer. PURPOSE: This clinical trial is studying the quality of life in patients receiving treatment for esophageal cancer.
What is the current status of trial NCT00003381?
This trial is currently terminated. The enrollment target is 56 participants. The study started on 1998-07. Estimated completion is 2005-01.
Who is sponsoring clinical trial NCT00003381?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.